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TATA-box-binding protein (TBP)-related factor 3, TRF3 (also called TBP2), is a vertebrate-specific member of the TBP family that has a conserved carboxy-terminal region and DNA-binding domain virtually identical to that of TBP (ref. 1). TRF3 is highly expressed during embryonic development, and studies in zebrafish and Xenopus have shown that it is required for normal embryogenesis 2, 3 . Here we show that zebrafish embryos depleted of Trf3 exhibit multiple developmental defects and, in particular, fail to undergo haematopoiesis. Expression profiling for Trf3-dependent genes identified mespa, which encodes a transcription factor whose murine orthologue is required for mesoderm specification 4 , and chromatin immunoprecipitation verified that Trf3 binds to the mespa promoter. Depletion of Mespa resulted in developmental and haematopoietic defects markedly similar to those induced by Trf3 depletion. Injection of mespa messenger RNA (mRNA) restored normal development to a Trf3-depleted embryo, indicating mespa is the single Trf3 target gene required for zebrafish embryogenesis. Zebrafish embryos depleted of Trf3 or Mespa also failed to express cdx4, a caudal-related gene required for haematopoiesis. Mespa binds to the cdx4 promoter, and epistasis analysis revealed an ordered trf3-mespa-cdx4 pathway. Thus, in zebrafish, commitment of mesoderm to the haematopoietic lineage occurs through a transcription factor pathway initiated by a TBP-related factor.
To analyse the role of TRF3 during embryonic development, we used antisense morpholino oligonucleotides to ablate Trf3, and as a control Tbp, function in zebrafish embryos. Morpholino oligonucleotides were injected into wild-type one-cell stage fertilized embryos, and depletion of Trf3 and Tbp was analysed by immunoblotting at 6 h post-fertilization (h.p.f.), a time at which expression of both proteins was readily detectable (Supplementary Fig. 1a ). Immunoblot analysis confirmed that injection of each morpholino oligonucleotide efficiently and specifically depleted its target gene ( Supplementary Fig. 1b) . Consistent with previous studies 5 , Tbpdepleted embryos appeared to initiate gastrulation but failed to progress past 50% epiboly (Supplementary Fig. 2 ; n 5 122/150). By contrast, Trf3-depleted embryos appeared to develop normally until the tailbud stage, but by 14 h.p.f. they exhibited delayed development and necrosis compared with siblings injected with a randomized control morpholino oligonucleotide (n 5 166/177). Inspection of Trf3-depleted embryos at 21 h.p.f. revealed severe necrosis, although head, trunk and tail rudiments were apparent, suggesting that initial antero-posterior patterning was largely unaffected.
To identify Trf3 target genes, we performed expression profiling in trf3 morpholino-oligonucleotide-treated embryos (at 6 h.p.f.) using a zebrafish oligonucleotide microarray representing about 12,800 genes. As expected, most genes were unaffected by Trf3 depletion (Supplementary Information). Three such representative genes are shown as controls in the reverse transcription-polymerase chain reaction (RT-PCR) experiment in Fig. 1a , which confirms that their expression is dependent upon Tbp but not Trf3. Using a candidatebased approach, we selected genes whose expression was significantly decreased by Trf3 knockdown (Supplementary Table 1 The RT-PCR results (Fig. 1a) show that Trf3 depletion eliminated mespa expression. To determine whether mespa was a direct Trf3 target, we analysed promoter occupancy by ChIP assays using antibodies directed against Trf3, Tbp, RNA polymerase II (Pol II) or, as a negative control, an irrelevant protein (yeast Gal4). As controls, we analysed two well-characterized housekeeping genes, actin and gapdh. Figure 1b shows that Pol II was bound to all three promoters, consistent with the transcriptional activity of these genes. Notably, Tbp but not Trf3 was bound to the actin promoter, whereas both Tbp and Trf3 were bound to the gapdh promoter. By contrast, the mespa promoter was selectively bound by Trf3 and not Tbp. Based upon the dependence of mespa expression on Trf3 (Fig. 1a) and the selective binding of Trf3 to the mespa promoter (Fig. 1b) , we conclude that mespa is a direct Trf3 target gene.
Phenotypic analysis demonstrated that the mespa morpholinooligonucleotide-injected embryo had a developmental defect that was strikingly similar to that of a Trf3-depleted embryo (n 5 61/89) ( Fig. 1c and Supplementary Fig. 3 ). As a control, injection of a mespa mRNA bearing a silent mutation that prevented hybridization with the mespa morpholino oligonucleotide restored normal development to the Mespa-depleted embryo ( Supplementary Fig. 4 ). To compare the phenotypes of the Trf3-and Mespa-depleted embryos in greater detail, we performed whole-mount in situ hybridization using several developmentally regulated genes as markers. Figure 1d shows that depletion of either Trf3 or Mespa resulted in increased shh expression in axial mesoderm, decreased nkx2.5 expression in cardiac mesoderm and decreased gata1 expression in lateral mesoderm. Surprisingly, expression of a second lateral mesoderm marker, pax2, was unaffected by loss of Trf3 or Mespa. Moreover, expression of the ventral marker bmp4 was normal in Trf3-and Mespa-depleted embryos, indicating that the developmental defects were not due to loss of proper dorsalventral patterning. Thus the developmental defect observed in Mespadepleted embryos was very similar, if not identical, to that of Trf3-depleted embryos.
We next asked whether ectopic expression of mespa could restore normal development to a Trf3-depleted embryo. Figure 1e shows that injection of mespa mRNA (n 5 110/134), but not an unrelated control mRNA (n 5 0/63; data not shown), restored normal development to the trf3 morpholino-oligonucleotide-injected embryo. Completeness of rescue was verified by differential interference contrast microscopy ( Supplementary Fig. 5 ) and in situ hybridization analysis ( Supplementary Fig. 6 ). Collectively, these results indicate that in zebrafish, mespa is the single Trf3 target gene required for proper embryonic development.
The results shown in Fig. 1d suggested a requirement for Trf3 and Mespa during development of cell types in the lateral mesoderm, which we analysed in greater detail by assaying the expression of several haematopoietic, vascular and pronephric markers in trf3 or mespa morpholino-oligonucleotide-injected embryos. The RT-PCR results shown in Supplementary Fig. 7 indicate that several bloodcell-specific genes were significantly downregulated in Trf3-and Mespa-depleted embryos. These include hbae1 and hbae3, which are terminal markers of erythroid cell fate, as well as gata1, which is required for the expression of a variety of genes in the erythroid lineage. In addition, earlier markers of haematopoietic precursors, scl and lmo2, were similarly reduced although expression of gata2 was unaffected. Finally, expression of pu.1, a marker of myeloid cells that arise in the anterior lateral mesoderm, was also reduced in the absence of Trf3 or Mespa.
To confirm the RT-PCR results, we analysed the expression of these marker genes by whole-mount in situ hybridization. Figure 2a shows that in trf3 or mespa morpholino-oligonucleotide-injected embryos, scl expression was reduced in the posterior lateral mesoderm, although expression was maintained within more anterior cells whose position is consistent with that of endothelial cells 6, 7 . Expression of lmo2 was moderately reduced in the posterior lateral mesoderm in Trf3-and Mespa-depleted embryos, whereas pu.1 expression was absent from the anterior lateral mesoderm. Also consistent with the RT-PCR results, expression of the early haematopoietic marker gata2 was unaffected by loss of Trf3 or Mespa. Similarly, expression of the endothelial cell marker kdr was normal in embryos lacking Trf3 or Mespa. As expected, injection of mespa mRNA into Trf3-depleted embryos fully rescued expression of the haematopoietic markers gata1 (see below), hbae1 and scl ( Supplementary Fig. 6 ), as well as the cardiac mesoderm marker nkx2.5 ( Supplementary Fig. 6 ).
Collectively, the results shown in Fig. 2a suggest a 
The defects in haematopoietic development described above are reminiscent of those observed in embryos lacking Cdx4, a caudalrelated transcription factor that is required for haematopoiesis 6 and which functions by activating expression of homeobox genes involved in the commitment of mesoderm to the haematopoietic lineage 6, 8 . RT-PCR and in situ hybridization showed that cdx4 expression was substantially decreased in Trf3-depleted embryos, as well as in Mespa-depleted embryos (Fig. 3a) . As expected, expression of the Cdx4-dependent genes hoxa9a, hoxb7a and hoxb5a 8 was also substantially reduced in Trf3-and Mespa-depleted embryos ( Supplementary Fig. 8 ). Depletion of Trf3 or Mespa did not affect expression of cdx1a ( Supplementary Fig. 9 ), which has been reported to cooperate with cdx4 in haematopoietic development 8 . In situ hybridization revealed that at 6 h.p.f. cdx4, mespa and trf3 were co-expressed in the presumptive haematopoietic tissues based on the zebrafish fate map 9, 10 (Fig. 3b) , suggesting that the three factors are components of a common pathway. To confirm this idea and LETTERS to determine the order of the pathway, we performed epistasis experiments using gata1 expression as a phenotypic read-out. Figure 3c shows that injection of trf3 mRNA restored gata1 expression in Trf3-depleted embryos, but not in Mespa-and Cdx4-depleted embryos, indicating that trf3 is upstream of both mespa and cdx4. Moreover, injection of mespa mRNA restored gata1 expression in Trf3-and Mespa-depleted embryos, but not in Cdx4-depleted embryos, indicating that mespa is upstream of cdx4 and downstream of trf3. Finally, injection of cdx4 mRNA restored gata1 expression in Trf3-, Mespa-and Cdx4-depleted embryos, indicating that cdx4 is downstream of both trf3 and mespa. ChIP analysis supports the possibility that cdx4 is a direct Mespa target gene ( Supplementary  Fig. 10a) .
Previous studies have shown that ectopic expression of cdx4 in zebrafish results in increased numbers of blood cells, as evidenced by expanded expression of haematopoietic markers 6 . Ectopic expression of mespa also resulted in expanded expression of gata1 and scl (Fig. 3d) and cdx4 (Fig. 3e) . The collective results of Figs 2 and 3 reveal that trf3, mespa and cdx4 function in a common pathway, which is summarized in Supplementary Fig. 10b .
Collectively, our results indicate that binding of Trf3 to the mespa promoter is the earliest documented step in committing mesoderm to the haematopoietic lineage in the developing zebrafish embryo. A recent study has provided definitive evidence for the existence of hemangioblasts, bipotential progenitors that can give rise to both endothelial and haematopoietic cells, within the zebrafish embryo 10 . Importantly, in zebrafish embryos, hemangioblasts are present at the same time and place in which trf3, mespa and cdx4 are expressed. Thus, the timing and location of trf3, mespa and cdx4 co-expression suggests that this transcription factor pathway may function within hemangioblasts to specify haematopoietic progenitor cells (that is, commitment of mesoderm to the haematopoietic lineage). Although the defects associated with loss of Trf3 or Mespa are restricted to haematopoietic cell types in the lateral mesoderm, the effects on other tissues appear to be more widespread. We predict that there will be additional Mespa target genes that function analogously to but independently of cdx4 in mediating other developmental pathways, such as specification of cardiac mesoderm, in the early embryo.
METHODS SUMMARY
Zebrafish maintenance, embryo production and microinjection. Zebrafish (Danio rerio) were maintained under standard conditions 11 , and embryos were produced and staged as described 12 . Antisense morpholino oligonucleotides were designed against the start codon/59 untranslated region to block translation. Morpholino oligonucleotide sequences were as follows: control morpholino oligonucleotide, 59-CCTCTTACCTCAGTTACAATTTATA-39; trf3 morpholino oligonucleotide, 59-GATGCCTCCTCATCCATGTTCAT-39; and mespa morpholino oligonucleotide, 59-GAAGAGAAAACGTGGAGGCGTCCAT-39. The cdx4 morpholino oligonucleotide (59-CTCCAAAAGGTATCCAACGTACATG-39) was purchased from Open Biosystems, and the tbp morpholino oligonucleotide has been previously described 5 . Morpholino oligonucleotides were injected at a concentration of 5 mg ml
21
, except the cdx4 morpholino oligonucleotide, which was injected at 0.2 mg ml
. Embryos were analysed morphologically up to 24 h after injection.
To generate mRNAs for phenotypic rescue and epistasis experiments, fulllength trf3, mespa and cdx4 genes were amplified from shield-stage complementary DNA (cDNA) by RT-PCR (primer sequences are listed in Supplementary  Table 2) , and subcloned into pCS2 (ref. 13 ) for mRNA synthesis. The mRNAs were then injected into morpholino-oligonucleotide-treated or wild-type embryos at the one-to two-cell stage at concentrations of 100 ng ml 21 , 200 ng ml 21 and 30 ng ml 21 for trf3, mespa and cdx4, respectively. Immunoblot analysis. Protein extracts were prepared from zebrafish embryos as described 11 . Blots were probed with either an a-zebrafish Trf3 polyclonal antibody raised to the unique amino-terminal region of zebrafish Trf3 (CPQKESTQADIDTSNS; amino acids 90-105), or an a-human TRF3 polyclonal 1 , a-TBP monoclonal (3G3; Eurogentec), or a-RNA Pol II monoclonal (8WG16; Covance Research Products) antibody.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Microarray analysis. Total RNA was prepared from 50 control-morpholinooligonucleotide-or trf3 morpholino-oligonucleotide-injected zebrafish embryos 6 h after morpholino oligonucleotide treatment using Trizol reagent (Invitrogen). The KCC 17K Zebrafish Microarray was constructed using a commercially available 17K Zebrafish OligoLibrary consisting of 16,399 oligonucleotides (XEBLIB96; Compugen/Sigma-Genosys), corresponding to about 12,800 genes, based on UniGene clusters. Microarray construction, hybridization and scanning were performed at the Kimmel Cancer Center Microarray Core Facility at Thomas Jefferson University. Chips were scanned by using a Perkin Elmer ScanArray XL5000 Scanner, software version 3.1; images were quantified by PerkinElmer QuantArray Software 3.0. The raw data for all genes induced or repressed by trf3 morpholino oligonucleotide treatment is provided in the Supplementary Information. Background threshold values were determined for both microarrays and calculated as the mean plus two (for the trf3 morpholino oligonucleotide microarray) or three (for the control morpholino oligonucleotide microarray) standard deviations of the channel intensities for the five bacterial probes present on each array. The background threshold values were then subtracted from the channel intensity value of each probe set (representing a single gene). The resulting data from the two microarrays were compared to identify Trf3-affected genes, which were classified as those whose probe values satisfied the following condition: greater than 0 in the control microarray (that is, the gene is significantly expressed over background) and no more than 0 in the trf3 morpholino oligonucleotide microarray (that is, the gene is significantly downregulated, essentially 'off', upon Trf3 depletion); these genes are listed in the 'Analysed data' tab in the Supplementary Data. To determine transcript identity and gene descriptions, we first annotated the gene list by identifying Unigene numbers (Unigene build 104) that corresponded with the GenBank accession number for each oligonucleotide on the array. We subsequently annotated gene names and descriptions through downloadable data sets obtained from the Zebrafish Information Network (ZFIN) and ENSEMBL (Zv7). In each case, we used FileMaker Pro to generate relational databases to annotate gene sets. RT-PCR. RT-PCR analysis was performed according to standard protocols 14 . Total RNA was prepared using Trizol reagent (Invitrogen) and RT-PCR products were separated by agarose gel electrophoresis and visualized by autoradiography. Primer sequences are listed in Supplementary Table 2 . Chromatin immunoprecipitation. Embryos (about 3,000 at 6 h.p.f.) were washed in 13 PBS three times, suspended in 13 PBS containing 1% formaldehyde (final concentration), transferred to a 10 ml dounce homogenizer and then dounced in one stroke. The reaction mixture was incubated at room temperature for 15 min and quenched by addition of glycine (0.125 M final concentration) for 10 min. The cells were centrifuged at 14,000 r.p.m. (16,100 g) for 10 min at 4 uC, and the pellets were washed twice with ice-cold 13 PBS containing protease inhibitors, and resuspended in 5 ml lysis buffer (50 mM HEPES-KOH, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 1 mM PMSF, and protease inhibitor cocktail). The suspension was then sonicated eight times on ice to generate approximately 500 base-pair fragments. The lysates were centrifuged, pre-cleared with protein-A agarose beads (Upstate Biotech), and then divided into 1.5 ml aliquots per immunoprecipitation. Antibodies for immunoprecipitation were as follows: Trf3, Tbp and Pol II antibodies are described in the Methods Summary; the Mespa antibody was raised to the C-terminal portion of the protein (CYQTQNPVQGDFHS; amino acids 191-204); yeast Gal4 (sc577; Santa Cruz). After addition of the antibody, lysates were incubated for 12 h at 4 uC, and then incubated with protein-A agarose beads (50 ml) for 2 h at 4 uC (5% of the lysate was kept as 'input' before the addition of the antibody). The beads were washed twice with lysis buffer without protease inhibitor, twice with the lysis buffer containing 1 M NaCl, and once with LiCl
